#National Institutes of Health

NIH researchers have prompted animals to develop broadly neutralizing antibodies against the virus; an early human trial is in the works.

Promising news on the prevention front

The All of Us Research Program aims to collect data from 1 million people.

It’s the NIH’s first large-scale clinical trial on the subject. Plus: Meet organ transplant advocate Mo Murray [VIDEO].

Aside from taking antiretrovirals, quitting smoking is the number one way people with HIV can lower their risk of illness and death.

Researchers will genetically engineer participants’ CD4 cells, disabling the attachment of the virus.

At stake in amfAR’s civil war is the nonprofit’s quest to find a cure for HIV.

The CDC would keep fewer than 40 percent on employers on the job—and this is during a deadly flu outbreak.

This NIH study closely monitored 10 people with HIV who stopped antiretroviral treatment for weeks to months in a larger cure study.

A $3.4 million grant funds research about the HIV prevention pill in Milwaukee and Cleveland.

A one-month version of the ring is currently up for regulatory approval.

Courting controversy, the NIH considers a shift away from the development of new vaginal or rectal-based HIV prevention products.

A statement from the National Institutes of Health on World AIDS Day 2017.

A trial of long-acting cabotegravir injected every eight weeks is already under way among men who have sex with men and trans women.

The study of a vaccine that is designed to prevent multiple strains of the virus will include 2,600 women in sub-Saharan Africa.

A federal grant will help develop an HIV prevention app called Transwoman Connected.